PRESS RELEASE published on 08/23/2024 at 23:00, 1 year 7 months ago urban-gro, Inc. Receives Nasdaq Notification of Non-Compliance with Listing Rule 5250(c)(1) urban-gro, Inc. received a notice from Nasdaq due to delayed filing of financial reports, plans to regain compliance within specified timeline. Details on restating financial statements provided Compliance Nasdaq Financial Reports Urban-gro Restating Financial Statements
BRIEF published on 08/14/2024 at 15:05, 1 year 7 months ago Urban-gro, Inc. Announces Delayed 10-Q Filing and Restatement of Financial Statements Accounting Errors Financial Restatement Urban-gro Q2 Revenue Deferred Tax Liabilities
BRIEF published on 08/14/2024 at 15:05, 1 year 7 months ago Urban-gro, Inc. annonce le report du dépôt du formulaire 10-Q et le retraitement des états financiers Urbain-gro Retraitement Financier Chiffre D'affaires Du T2 Erreurs Comptables Passif D'impôt Différé
PRESS RELEASE published on 08/14/2024 at 15:00, 1 year 7 months ago urban-gro, Inc. Announces Delayed 10-Q Filing and Restatement of Previously Issued Financial Statements Tied to Incorrect Accounting of Deferred Tax Liabilities Associated with Historical Acquisitions urban-gro, Inc. announces restatement of financial statements for 2022, 2023, and Q1 2024, appoints new audit firm Sadler Gibb, identifies accounting errors, no expected material impact on revenues, EBITDA, or cash flows Revenues Financial Statements Restatement Accounting Errors Urban-gro Inc. Sadler Gibb
BRIEF published on 07/12/2024 at 15:56, 1 year 8 months ago Urban-gro, Inc. Gains Momentum with New Contracts Investment Opportunities Cannabis Sector Urban-gro, Inc. DOJ Reclassification Florida Legalization
BRIEF published on 07/12/2024 at 15:56, 1 year 8 months ago Urban-gro, Inc. prend de l'ampleur avec de nouveaux contrats Opportunités D'investissement Urban-gro, Inc. Secteur Du Cannabis Reclassement Du DOJ Légalisation En Floride
PRESS RELEASE published on 07/12/2024 at 15:51, 1 year 8 months ago Original-Research: urban-gro, Inc. (von First Berlin Equity Research GmbH): Kaufen First Berlin Equity Research issued an update on urban-gro, Inc. (US91704K2024) with Buy rating and $4.30 target price. Recent contracts hint at expanding cannabis market amid changing US policies First Berlin Equity Research BUY Rating Cannabis Market Urban-gro Inc. US Policy Shift
BRIEF published on 06/26/2024 at 15:05, 1 year 9 months ago Urban-gro Secures $12M in New Cannabis Sector Contracts for Q2 Revenue Urban-gro Controlled Environment Agriculture Design-Build Cannabis Contracts
BRIEF published on 06/26/2024 at 15:05, 1 year 9 months ago Urban-gro obtient 12 millions de dollars dans de nouveaux contrats dans le secteur du cannabis pour le deuxième trimestre Urbain-gro Agriculture En Environnement Contrôlé Revenu Conception-construction Contrats De Cannabis
PRESS RELEASE published on 06/26/2024 at 15:00, 1 year 9 months ago urban-gro Signs Approximately $12M in New Cannabis Sector Contracts in the Second Quarter urban-gro, Inc. announces signing multiple new contracts in the cannabis sector, with expected contract revenue around $12 million. Company anticipates revenue recognition by Q3 2024 Revenue New Contracts Urban-gro Inc. Professional Services Cannabis Sector
Published on 03/26/2026 at 23:00, 14 minutes ago FutureGen Industries Announces Closing of Debt Settlement
Published on 03/26/2026 at 22:05, 1 hour 9 minutes ago BlackBerry to Announce Fourth Quarter and Fiscal Year 2026 Results on April 9, 2026
Published on 03/26/2026 at 22:00, 1 hour 14 minutes ago Clean Air Metals Receives Provincial Funding and Provides Update on the Thunder Bay North Project
Published on 03/26/2026 at 22:00, 1 hour 14 minutes ago Green Bridge Metals Reports Visible Copper Sulfide Mineralization in Initial 2026 Titac Drilling, Duluth Complex Minnesota
Published on 03/26/2026 at 21:00, 2 hours 14 minutes ago Worksport Reports Record FY 2025 Results, Issues $35M–$42M 2026 Revenue Guidance; Targets Initial Cash Flow Positivity
Published on 03/26/2026 at 20:48, 2 hours 26 minutes ago Dermapharm Holding SE repurchases 4,299,190 shares under its public share buyback offer
Published on 03/26/2026 at 19:20, 3 hours 54 minutes ago Critical Path Institute Launches 'One to Millions' to Reshape the Future of Individualized Medicine at Global Scale
Published on 03/26/2026 at 19:09, 4 hours 5 minutes ago 2CRSi SA: Résultats 1er Semestre 2025/26 : Chiffre d'Affaires 204,7 M€ (x9,8) EBITDA de 9,6 M€ (x4,6)
Published on 03/26/2026 at 19:09, 4 hours 5 minutes ago 2CRSi SA: First Half 2025/26 Results: Revenue of €204.7 million (x9.8) EBITDA of €9.6 million (x4.6)
Published on 03/26/2026 at 18:17, 4 hours 57 minutes ago Eiffage se renforce au capital de Getlink et porte sa participation à 29,40 % du capital
Published on 03/26/2026 at 18:17, 4 hours 57 minutes ago Eiffage strengthens its position in Getlink capital
Published on 03/26/2026 at 18:00, 5 hours 14 minutes ago Arrêté des comptes au 31 décembre 2025 et perspectives 2026
Published on 03/26/2026 at 18:00, 5 hours 14 minutes ago LABORATOIRES EUROMEDIS - Fin du contrat de liquidité